Literature DB >> 25120828

Low-grade endometrioid carcinoma of the ovary associated with undifferentiated carcinoma: case report and review of the literature.

Ling Chen1, Shujie Pang1, Yan Shen1, Zaiping Liu2, Jing Luan1, Yiquan Shi1, Yixin Liu1.   

Abstract

The association of low-grade endometrioid carcinoma with undifferentiated carcinoma (UC) was first reported in endometrium carcinoma, termed with dedifferentiated carcinoma (DC). However, the coexistence of low-grade endometrioid carcinoma (LGEC) or serous carcinoma (LGSC) with UC has received minimal attention in ovary, and the behavior of this kind of neoplasm remains at further discussion. In this study, we reported a case of low-grade ovarian endometrioid carcinoma associated with UC and reviewed another four cases previously reported. We found a histological continuity between the LGEC and UC components in H&E section, which suggested a dedifferentiation from LGEC to UC components. In summary, this kind of pathological type has aggressive behavior and these patients have very poor prognosis regardless of the amount of undifferentiated carcinoma.

Entities:  

Keywords:  Ovarian carcinoma; dedifferentiated carcinoma; low-grade endometrioid carcinoma; undifferentiated carcinoma

Mesh:

Substances:

Year:  2014        PMID: 25120828      PMCID: PMC4129063     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  7 in total

1.  Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?

Authors:  Elvio G Silva; Michael T Deavers; Diane C Bodurka; Anais Malpica
Journal:  Int J Gynecol Pathol       Date:  2006-01       Impact factor: 2.762

2.  Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report.

Authors:  Yan Shen; Ying Wang; Yuquan Shi; Jinsong Liu; Yixin Liu
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

3.  Massive intra-abdominal undifferentiated carcinoma derived from an endometrioid adenocarcinoma in a "normal-sized" ovary.

Authors:  Kosuke Miyai; Sohei Yamamoto; Shinsuke Aida; Hideyuki Shimazaki; Masashi Takano; Kazuya Kudoh; Kenichi Furuya; Seiichi Tamai; Osamu Matsubara
Journal:  Int J Gynecol Pathol       Date:  2010-07       Impact factor: 2.762

4.  Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.

Authors:  Clinton Boyd; W Glenn McCluggage
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

5.  Dedifferentiated endometrioid adenocarcinoma of the uterus: a clinicopathologic study of a case.

Authors:  Giulia Vita; Ludovica Borgia; Luigina Di Giovannantonio; Michele Bisceglia
Journal:  Int J Surg Pathol       Date:  2011-04-28       Impact factor: 1.271

6.  Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer.

Authors:  Alessandro Antonelli; Guido Bocci; Concettina La Motta; Silvia Martina Ferrari; Poupak Fallahi; Anna Fioravanti; Stefania Sartini; Michele Minuto; Simona Piaggi; Alessandro Corti; Greta Alì; Piero Berti; Gabriella Fontanini; Romano Danesi; Federico Da Settimo; Paolo Miccoli
Journal:  J Clin Endocrinol Metab       Date:  2010-12-08       Impact factor: 5.958

Review 7.  Undifferentiated carcinoma of the endometrium: a review.

Authors:  Elvio G Silva; Michael T Deavers; Anais Malpica
Journal:  Pathology       Date:  2007-02       Impact factor: 5.306

  7 in total
  3 in total

1.  Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma.

Authors:  Felipe C Geyer; Fresia Pareja; Kathleen A Burke; Anne M Schultheis; Yaser R Hussein; Jiqing Ye; Maria R De Filippo; Caterina Marchio; Gabriel S Macedo; Salvatore Piscuoglio; Raymond S Lim; Eugene Toy; Rajmohan Murali; Achim A Jungbluth; Jorge S Reis-Filho; Robert A Soslow; Britta Weigelt
Journal:  Histopathology       Date:  2017-06-16       Impact factor: 5.087

2.  Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.

Authors:  Mackenzie Coatham; Xiaodong Li; Anthony N Karnezis; Lien N Hoang; Basile Tessier-Cloutier; Bo Meng; Robert A Soslow; C Blake Gilks; David G Huntsman; Colin J R Stewart; Lynne M Postovit; Martin Köbel; Cheng-Han Lee
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

3.  Extremely rare case of successful treatment of metastatic ovarian undifferentiated carcinoma with high-dose combination cytotoxic chemotherapy: A case report.

Authors:  Hong Beum Kim; Hee Jeong Lee; Ran Hong; Sang-Gon Park
Journal:  World J Clin Cases       Date:  2020-10-06       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.